Skip to content

Early Detection of Aortic Stenosis in the Community During Flu Vaccination

Early Detection of Aortic Stenosis in the Community: Role of Clinical and Echocardiographic Screening During Influenza Vaccination Multi-center, Prospective, Observational Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03250806
Acronym
FluClinic
Enrollment
167
Registered
2017-08-16
Start date
2017-09-11
Completion date
2017-11-30
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis

Keywords

aortic stenosis, auscultation, target echocardiography

Brief summary

Prospective cohort study to test the hypothesis that patients identified with severe aortic stenosis are under-diagnosed and under-treated. Such patients shall be identified by auscultation or target echocardiography during flu vaccination. The hypothesis is that this will increase detection of aortic stenosis in the community.

Detailed description

The design plans for two study phases: 1. Feasibility study: screening by auscultation and target echocardiography during flu vaccination in a single practice in Birmingham; 2. Screening study: multi-centre screening by auscultation or target echocardiography in geographically diverse general practices across the United Kingdom. In each phase, the patient will be identified by auscultation and target echocardiography. Management and onward referral will be at the clinical discretion of the GP. Results of clinical review, investigation, follow-up and management will be recorded at 3 months from that date.

Interventions

None listed

Sponsors

Edwards Lifesciences
CollaboratorINDUSTRY
Institut für Pharmakologie und Präventive Medizin
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged over 65years attending for influenza vaccination. * written informed consent to data collection

Exclusion criteria

* known aortic stenosis * previous aortic valve repair/replacement

Design outcomes

Primary

MeasureTime frameDescription
prevalence of aortic stenosisFrom date of examination until follow-up after three monthsDetermination of the prevalence of aortic stenosis detected on screening performed during flu vaccination.
comparison of detection rate of aortic stenosisFrom date of examination until follow-up after three monthsComparison of detection rates of aortic stenosis using target auscultation vs detection by target 2D echocardiography.

Secondary

MeasureTime frameDescription
Evaluation of qualitative estimation of calcium burden on 2D echocardiography as a marker of AS severitythree monthsMethod evaluation
Calculation of costs in screening with auscultation versus target 2DE in screening for AS to inform future cost-efficacy studies of screening for AS.three monthsCost evaluation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026